GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
If you are on both, B12 supplementation is not optional
Understanding the options available, from oral GLP-1 medications in development to next-generation combinations , helps contextualize where supplements actually fit
doi: 10.1016/j.jceh.2024.102446, 5
Scientific insight and access equity must advance together for the next era of autoimmune care
Prime Kraft L- ,